Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dror Ortho-Design, Inc.DROR · Entity 8012 | Director · Chief Executive Officer | June 17, 2024 | June 25, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dror Ortho-Design, Inc.
Report date June 17, 2024 · Filed June 25, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2034-06-17 | Direct | 95,965,715 |
Reported balance
After 2024-06-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-06-17 · Grant · Acquired 95,965,715 · Balance 95,965,715 F1: The stock options vested two-thirds upon the date of grant, and the remainder vests on December 6, 2024, subject to earlier vesting upon the achievement of patient use objectives, provided the Reporting Person is employed by or providing services to the Issuer or an affiliate on the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options vested two-thirds upon the date of grant, and the remainder vests on December 6, 2024, subject to earlier vesting upon the achievement of patient use objectives, provided the Reporting Person is employed by or providing services to the Issuer or an affiliate on the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2024 Filed Jun 25, 2024 17:28 UTC | Dror Ortho-Design, Inc. DROR · Entity 8012 | GrantStock Option (Right to Buy) · Derivative | 95,965,715 | $0.00 Strike: $0.00 | $355,073.15 |
DisclosureSEC source: 0001213900-24-055833 · ownership.xml · derivative · entry 1 Haddad Eliyahu · CIK 0001994035 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,965,715 Underlying: Common Stock · 95,965,715 shares Expires 2034-06-17 F1 · derivative.exercise_date: The stock options vested two-thirds upon the date of grant, and the remainder vests on December 6, 2024, subject to earlier vesting upon the achievement of patient use objectives, provided the Reporting Person is employed by or providing services to the Issuer or an affiliate on the applicable vesting date. Read SEC document |
| September 13, 2023 Filed Sep 27, 2023 21:33 UTC | Dror Ortho-Design, Inc. DROR · Entity 8012 | GrantCommon Warrants · Derivative | 45,454,545 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001387131-23-011683 · haddad-form4_091323.xml · derivative · entry 2 Haddad Eliyahu · CIK 0001994035 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,454,545 Underlying: Common Stock · 45,454,545 shares Expires not disclosed F3 · derivative.exercise_date: Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date"). F4 · derivative.expiration_date: Warrants expire on the fifth anniversary of the Initial Exercise Date. Read SEC document |
| September 13, 2023 Filed Sep 27, 2023 21:33 UTC | Dror Ortho-Design, Inc. DROR · Entity 8012 | GrantSeries A Convertible Preferred Stock · Derivative | 454,545.45 | $1.10 Strike: $0.01 | $500,000.00 |
DisclosureSEC source: 0001387131-23-011683 · haddad-form4_091323.xml · derivative · entry 1 Haddad Eliyahu · CIK 0001994035 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 454,545.45 Underlying: Common Stock · 45,454,545 shares Expires not disclosed F1 · derivative.exercise_date: Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock. F2 · derivative.expiration_date: The Preferred Stock is perpetual and therefore has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.